Overview
- Business Insider reported that affiliates ran thousands of Meta ads using what looked like AI‑generated doctor personas to promote Medvi, and active campaigns fell from over 5,000 to about 2,800 after the outlet flagged suspect pages to the company.
- The FDA issued a February warning letter saying content at medvi.io made false or misleading comparisons to FDA‑approved drugs and used images that implied Medvi compounded medications.
- Founder Matthew Gallagher said an affiliate operated medvi.io without permission and took it down after the warning, and he put affiliate ads at roughly 30% of Medvi’s marketing while noting the company used AI tools to build its site and content.
- Two lawsuits are pending that accuse Medvi and its marketers of sending unsolicited texts and emails, one earlier case was dropped, and the company denies illegal conduct and says it enforces a no‑spam policy.
- Consumer groups previously asked the FTC to investigate telehealth marketing, and critics now fault a positive New York Times profile for overlooking red flags like AI‑made images and fake endorsements, pointing to rising pressure on AI‑led health ads.